Skip to main content
. 2018 Aug 30;8(8):e023605. doi: 10.1136/bmjopen-2018-023605

Table 5.

Subgroup analyses: Kappa values

Subgroup Number (%) Kappa value
(95% CI)
Small molecule drugs 286 0.313 (0.205 to 0.420)
Biologics 99 0.233 (0.061 to 0.405)
Antineoplastic agents 71 0.091 (0.017 to 0.200)
Antivirals for systemic use 46 0.122 (0.011 to 0.233)
Immunosuppressants 35 0.376 (0.075 to 0.675)
All other therapeutic groups 357 0.385 (0.263 to 0.506)